Related references
Note: Only part of the references are listed.Biomarkers for Alzheimer Disease: Classical and Novel Candidates' Review
Nadia El Kadmiri et al.
NEUROSCIENCE (2018)
The Clock Drawing Test: A Reasonable Instrument to Assess Probable Dementia in Primary Care?
Katinka Reiner et al.
CURRENT ALZHEIMER RESEARCH (2018)
Cerebrospinal Fluid A beta(42/40) Corresponds Better than A beta(42) to Amyloid PET in Alzheimer's Disease
Piotr Lewczuk et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress
Ashvini Keshavan et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
Ewa Kozela et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Resolution of inflammation, n-3 fatty acid supplementation and Alzheimer disease: A narrative review
Vanessa Gomes Fraga et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2017)
Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain
Michal Arbel-Ornath et al.
MOLECULAR NEURODEGENERATION (2017)
Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes
Wei Qiang et al.
NATURE (2017)
Fibril structure of amyloid-β(1-42) by cryo-electron microscopy
Lothar Gremer et al.
SCIENCE (2017)
Dementia Caregiver Burden: a Research Update and Critical Analysis
Sheung-Tak Cheng
CURRENT PSYCHIATRY REPORTS (2017)
On the path to 2025: understanding the Alzheimer's disease continuum
Paul S. Aisen et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Dementia in Latin America: Epidemiological Evidence and Implications for Public Policy
Nilton Custodio et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us
Helene E. Hirbec et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Multicenter Analytical Validation of Aβ40 Immunoassays
Linda J. C. van Waalwijk van Doorn et al.
FRONTIERS IN NEUROLOGY (2017)
Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution
Martin Wolff et al.
SCIENTIFIC REPORTS (2017)
Lessons Learned: Transfer of the High-Definition Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform
P. Kuhn et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Pyroglutamate-Modified Amyloid (11-40) Fibrils Are More Toxic than Wildtype Fibrils but Structurally Very Similar
Holger A. Scheidt et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity
Rihards Aleksis et al.
BIOCHIMIE (2017)
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay
Kateryna Kravchenko et al.
BIOLOGICAL CHEMISTRY (2017)
sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body fluids
Yvonne Herrmann et al.
CLINICAL BIOCHEMISTRY (2017)
Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies
Yvonne Herrmann et al.
CLINICA CHIMICA ACTA (2017)
Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease
Santiago V. Salazar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Preparation of pure populations of covalently stabilized amyloid β-protein oligomers of specific sizes
Eric Y. Hayden et al.
ANALYTICAL BIOCHEMISTRY (2017)
Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease
Laura T. Haas et al.
BRAIN (2016)
Biofunctionalized Silica Nanoparticles: Standards in Amyloid-beta Oligomer-Based Diagnosis of Alzheimer's Disease
Maren Huelsemann et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Oligomers of Amyloid Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease
Laura T. Haas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The formation, function and regulation of amyloids: insights from structural biology
M. Landreh et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils
Michael T. Colvin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Bengt Winblad et al.
LANCET NEUROLOGY (2016)
Alzheimer disease: modeling an Aβ-centered biological network
D. Campion et al.
MOLECULAR PSYCHIATRY (2016)
Atomic-resolution structure of a disease-relevant Aβ(1-42) amyloid fibril
Marielle Aulikki Walti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance
Robert Tycko
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Amyloid β oligomers elicit mitochondrial transport defects and fragmentation in a time-dependent and pathway-specific manner
Yanfang Rui et al.
MOLECULAR BRAIN (2016)
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study
Marina Boccardi et al.
JAMA NEUROLOGY (2016)
Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
Katja Kuehbach et al.
FRONTIERS IN NEUROSCIENCE (2016)
Tau: The Center of a Signaling Nexus in Alzheimer's Disease
Shahzad S. Khan et al.
FRONTIERS IN NEUROSCIENCE (2016)
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Urmi Sengupta et al.
EBIOMEDICINE (2016)
Fibrils of Truncated Pyroglutamyl-Modified Aβ Peptide Exhibit a Similar Structure as Wildtype Mature Aβ Fibrils
Holger A. Scheidt et al.
SCIENTIFIC REPORTS (2016)
Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells
Anna Drews et al.
SCIENTIFIC REPORTS (2016)
Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges
Bruno Dubois et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Innovative diagnostic tools for early detection of Alzheimer's disease
Christoph Laske et al.
ALZHEIMERS & DEMENTIA (2015)
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
Adam C. Kaufman et al.
ANNALS OF NEUROLOGY (2015)
Amyloid imaging for dementia in clinical practice
John T. O'Brien et al.
BMC MEDICINE (2015)
The structure of fibrils from 'misfolded' proteins
Beat H. Meier et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)
Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models
Mikhail A. Kostylev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Antiparallel β-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-β Peptides When They Form 150-kDa Oligomers
Danting Huang et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Successive Stages of Amyloid-β Self-Assembly Characterized by Solid-State Nuclear Magnetic Resonance with Dynamic Nuclear Polarization
Alexey Potapov et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease
Yiling Xiao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Peptide dimer structure in an Aβ(1-42) fibril visualized with cryo-EM
Matthias Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Aβ40 and Aβ42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation
Risto Cukalevski et al.
CHEMICAL SCIENCE (2015)
Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease
Yiling Xiao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid
Ting Yang et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
A practical guide to immunoassay method validation
Ulf Andreasson et al.
FRONTIERS IN NEUROLOGY (2015)
Atomic-Resolution Three-Dimensional Structure of Amyloid β Fibrils Bearing the Osaka Mutation
Anne K. Schuetz et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Alternative salt bridge formation in Aβ-a hallmark of early-onset Alzheimer's disease?
Maarten Schledorn et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
A Hexameric Peptide Barrel as Building Block of Amyloid-β Protofibrils
Christofer Lendel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein
Mutsumi Mizoi et al.
CLINICA CHIMICA ACTA (2014)
Brain PET in the Diagnosis of Alzheimer's Disease
Charles Marcus et al.
CLINICAL NUCLEAR MEDICINE (2014)
A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
Mary J. Savage et al.
JOURNAL OF NEUROSCIENCE (2014)
EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers
Lina M. Vargas et al.
PLOS ONE (2014)
Physical and structural basis for polymorphism in amyloid fibrils
Robert Tycko
PROTEIN SCIENCE (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Amyloid positron emission tomography with 18F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease
Ranjan Duara et al.
ALZHEIMERS & DEMENTIA (2013)
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
Ting Yang et al.
ALZHEIMERS & DEMENTIA (2013)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
Molecular Structure of β-Amyloid Fibrils in Alzheimer's Disease Brain Tissue
Jun-Xia Lu et al.
CELL (2013)
Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds
Massimo Stefani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The Alzheimer's Amyloid-β(1-42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization
William M. Tay et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
Mikko Holtta et al.
PLOS ONE (2013)
Amyloid-beta induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease
Ji Won Um et al.
PRION (2013)
Neural correlates of the DemTect in Alzheimer's disease and frontotemporal lobar degeneration - A combined MRI & FDG-PET study
Timo B. Woost et al.
NEUROIMAGE-CLINICAL (2013)
Glucose metabolism in normal aging and Alzheimer's disease: methodological and physiological considerations for PET studies
Lisa Mosconi
CLINICAL AND TRANSLATIONAL IMAGING (2013)
An Asymmetric Dimer as the Basic Subunit in Alzheimer's Disease Amyloid beta Fibrils
Juan Miguel Lopez del Amo et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
Oligomers of beta-amyloid protein (Aβ1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1beta, tumour necrosis factor-alpha, and a nuclear factor kappa-B mechanism in the rat brain
I. Carrero et al.
EXPERIMENTAL NEUROLOGY (2012)
Solid-state NMR Reveals a Close Structural Relationship between Amyloid-β Protofibrils and Oligomers
Holger A. Scheidt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Structural Properties of EGCG-Induced, Nontoxic Alzheimer's Disease Aβ Oligomers
Juan Miguel Lopez del Amo et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Oligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of Toxicity
Marcus Faendrich
JOURNAL OF MOLECULAR BIOLOGY (2012)
Measurement of Aß1-42 in cerebrospinal fluid is influenced by matrix effects
J. Randall Slemmon et al.
JOURNAL OF NEUROCHEMISTRY (2012)
The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease
Megan Larson et al.
JOURNAL OF NEUROSCIENCE (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Ji Won Um et al.
NATURE NEUROSCIENCE (2012)
Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils
Wei Qiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Toxic fibrillar oligomers of amyloid-β have cross-β structure
James C. Stroud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Detection of α-Synuclein Aggregates by Fluorescence Microscopy
S. Huebinger et al.
REJUVENATION RESEARCH (2012)
Solid-State NMR Spectroscopic Investigation of A beta Protofibrils: Implication of a beta-Sheet Remodeling upon Maturation into Terminal Amyloid Fibrils
Holger A. Scheidt et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
Victor L. Villemagne et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Structural Evolution of Iowa Mutant β-Amyloid Fibrils from Polymorphic to Homogeneous States under Repeated Seeded Growth
Wei Qiang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
A New Structural Model of Aβ40 Fibrils
Ivano Bertini et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
Henryk Barthel et al.
LANCET NEUROLOGY (2011)
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2010)
Mysterious oligomerization of the amyloidogenic proteins
Vladimir N. Uversky
FEBS JOURNAL (2010)
Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity
Massimo Stefani
FEBS JOURNAL (2010)
β-amyloid oligomers and cellular prion protein in Alzheimer's disease
Erik C. Gunther et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Synthesis and Characterization of Stable Monodisperse Silica Nanoparticle Sols for in Vitro Cytotoxicity Testing
Leen C. J. Thomassen et al.
LANGMUIR (2010)
Wnt-5a occludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons
Waldo Cerpa et al.
MOLECULAR NEURODEGENERATION (2010)
Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils
Mahiuddin Ahmed et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering
Anders Sandberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Cellular Prion Protein Mediates the Toxicity of β-Amyloid Oligomers
Haakon B. Nygaard et al.
ARCHIVES OF NEUROLOGY (2009)
Biophysical Analyses of Synthetic Amyloid-β(1-42) Aggregates before and after Covalent Cross-Linking. Implications for Deducing the Structure of Endogenous Amyloid-β Oligomers
Brenda D. Moore et al.
BIOCHEMISTRY (2009)
Optimized straight forward procedure for covalent surface immobilization of different biomolecules for single molecule applications
Richard Janissen et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aβ(1-40) Fibril Polymorphism Implies Diverse Interaction Patterns in Amyloid Fibrils
Jessica Meinhardt et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Oligomerization Partially Explains the Lowering of A beta 42 in Alzheimer's Disease Cerebrospinal Fluid
Hillevi Englund et al.
NEURODEGENERATIVE DISEASES (2009)
Interprotofilament interactions between Alzheimer's Aβ1-42 peptides in amyloid fibrils revealed by cryoEM
Rui Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Comparison of Alzheimer Aβ(1-40) and Aβ(1-42) amyloid fibrils reveals similar protofilament structures
Matthias Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure
Anant K. Paravastu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neurobiology ofAlzheimer′s disease
E Mohandas et al.
Indian Journal of Psychiatry (2009)
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2008)
Aβ inhibits the proteasome and enhances amyloid and tau accumulation
Bertrand P. Tseng et al.
NEUROBIOLOGY OF AGING (2008)
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
Fernanda G. De Felice et al.
NEUROBIOLOGY OF AGING (2008)
Paired β-sheet structure of an Aβ(1-40) amyloid fibril revealed by electron microscopy
Carsten Sachse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
Wolfgang Hoyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils
Anant K. Paravastu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid
Sandra Chimon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Comparison of different aminofunctionalization strategies for attachment of single antibodies to AFM cantilevers
Andreas Ebner et al.
ULTRAMICROSCOPY (2007)
Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine
Fernanda G. De Felice et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Prediction of Alzheimer's disease using the CSF A beta 42/A beta 40 ratio in patients with mild cognitive impairment
Oskar Hansson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Leslie M. Shaw et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Optimization of silica silanization by 3-aminopropyltriethoxysilane
John A. Howarter et al.
LANGMUIR (2006)
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease
CG Glabe
NEUROBIOLOGY OF AGING (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Global prevalence of dementia: a Delphi consensus study
CP Ferri et al.
LANCET (2005)
Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils
AT Petkova et al.
SCIENCE (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia
E Kalbe et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-β peptide
B Kriem et al.
FASEB JOURNAL (2004)
Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
T Sunderland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
F Bard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Paradigm shifts in Alzheimer's disease and other neuro degenerative disorders: The emerging role of oligomeric assemblies
MD Kirkitadze et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Amyloid β-protein oligomerization -: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins
G Bitan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
N Andreasen et al.
ARCHIVES OF NEUROLOGY (2001)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Share Paper
